NIH funds U.S. small businesses partnering with nonprofit research institutions to commercialize scientific innovations, supporting feasibility studies through later-stage research and development.
Funder: National Institutes of Health
Due Dates: September 5, 2026 (Applications) | January 5, 2027 (Applications) | April 5, 2027 (Applications)
Funding Amounts: Component-specific budgets below; normally up to 1 year for Phase I and 2 years for Phase II; no match required
Summary: Supports U.S. small businesses partnering with nonprofit research institutions to develop and commercialize health-related scientific innovations.
Key Information: The small business must perform at least 40% of research effort, and its single research partner at least 30%.
NIH’s Small Business Technology Transfer program funds research and development that moves scientific innovations toward commercial products. This parent opportunity, PA-27-102, supports feasibility studies through later-stage development aligned with participating NIH Institutes’ and Centers’ missions. Projects require a formal collaboration between a U.S. small business and a nonprofit research institution or qualifying federally funded research and development center. The award is always made to the small business.
Applications may seek Phase I, Phase II, Direct to Phase II, or Fast-Track support. Clinical trials are optional, subject to component-specific exclusions. After Phase II, NIH expects recipients to commercialize their products or technologies using non-SBIR/STTR funding.